Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine a in organ transplantation
Padberg, W.M.; Morgalla, H.; Buhr, J.; Hild, P.; Schwemmle, K.
Transplantation Proceedings 23(1 Part 1): 348
1991
ISSN/ISBN: 0041-1345 PMID: 1671302 Document Number: 368280
Document emailed within 1 workday
Related Documents
Whitehouse, I.; Beglinger, C.; Fried, M.; Gyr, K. 1984: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man Hepato-Gastroenterology 31(5): 227-229Gorden, P.; Comi, R.J.; Maton, P.N.; Go, V.L. 1989: NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Annals of Internal Medicine 110(1): 35-50
Claro, A.; Grill, V.; Efendić, S.; Luft, R. 1977: Studies on the mechanisms of somatostatin action on insulin release. IV. effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated rat pancreatic islets Acta Endocrinologica 85(2): 379-388
Miranda-Ruiz, R.; Castañón-González, J.; Pérez Aldana, C.; Arias, E.; Díaz de León Ponce, M.; Zárate, A. 1990: Effect of a synthetic somatostatin analogue with delayed action (SMS 201-995) on the biliary expenditure in a patient with an external biliary tract fistula Revista de Gastroenterologia de Mexico 55(2): 67-69
Tulassay, Z.; Németh, J.; Varga, G.; Papp, M. 1991: Effect of somatostatin analogue on experimental pancreatic lesions and their sequelae Orvosi Hetilap 132(30): 1631-1638
Campagnolo, D.; Gower, W.R.; Fabri, P.J.; Sparks, J.; Mekhjian, H.S.; O'Dorisio, T.M.; Ellison, E.C. 1987: Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma Surgery 102(6): 982-987
Estève, J.P.; Susini, C.; Vaysse, N.; Gineston, J.L.; Pradayrol, L.; Wunsch, E.; Ribet, A. 1982: Effect of somatostatin 14, as natural and synthetic somatostatin 28 on pentagastrin-stimulated gastric acid and pancreatic secretions in conscious dogs Gastroenterologie Clinique et Biologique 6(6-7): 576-580
Wahlers, T.; Mügge, A.; Oppelt, P.; Heublein, B.; Fieguth, H.G.; Jurmann, M.; Haverich, A. 1994: Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog Transplantation Proceedings 26(5): 2741-2742
Ko, T.C.; Bertram, M.F.; Prinz, R.A.; Castelli, M.; Djuricin, G.; Jacobs, H.K. 1992: Effect of somatostatin analogue and cholecystokinin receptor antagonist on bile-induced acute canine pancreatitis American Surgeon 58(4): 213-219
Tulassay, Z.; Kisfalvi, K.; Papp, M. 1995: The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats Zeitschrift für Gastroenterologie 33(2): 99-102
Padberg, W.M.; Di Stefano, R.; Lord, R.H.; Araneda, D.; Strom, T.B.; Diamantstein, T.; Tilney, N.L.; Kupiec-Weglinski, J.W. 1987: Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation Transplantation Proceedings 19(5): 4234-4235
Döbrönte, Z.; Stöckert, A.; Végh, G.; Varga, L. 1992: Treatment of carcinoid syndrome with a somatostatin analogue Orvosi Hetilap 133(12): 731-734
Yoshioka, M. 1986: Elevation of somatostatin content, and reduction of somatostatin release by GABA in rat pancreatic islets Kobe Journal of Medical Sciences 32(1): 27-38
O'Carroll, A.M.; Lolait, S.J.; König, M.; Mahan, L.C. 1993: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28 Molecular Pharmacology 44(6): 1278
Niv, Y.; Hadari, A.; Asaf, V.; Oren, M. 1991: Closure of postoperative anastomotic fistulas with a somatostatin analogue Harefuah 120(11): 647-648
Falhammar, H. 2009: Cyclic ectopic Cushing's syndrome and somatostatin analogue treatment New Zealand Medical Journal 122(1294): 92-95
Wang, C.; Lu, X.; Chen, Y. 2000: Effects of somatostatin and its analogue on canine sphincter of Oddi motility Zhonghua Yi Xue Za Zhi 80(8): 621-623
Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559
Morali, G.A.; Braverman, D.Z.; Shemesh, D.; Abramovitz, Z.; Jacobsohn, W.Z. 1991: Successful treatment of pancreatic pseudocyst with a somatostatin analogue and catheter drainage American Journal of Gastroenterology 86(4): 515-518
Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741